Cafepharma Today

Memorial Day Weekend 2025
We wish all our US visitors a safe and enjoyable holiday weekend. We remember those who have given their lives to defend and protect our country.

CP Today will resume on Tuesday, May 27

*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Shares Of A Biotech Company That DIDN'T Make The Drug That Saved The Ebola-Infected Doctor Are Surging
Yahoo/Business Insider
Thursday, August 21, 2014 - 8:30am
tags:
Tekmira, ebola virus
5 Things Eli Lilly and Co's Management Wants You to Know
Motley Fool
Thursday, August 21, 2014 - 8:25am
tags:
Eli Lilly, M&A, diabetes, oncology
Novan’s Topical Treatment Shows Efficacy Against Drug-resistant Bugs
Drug Discovery and Development
Thursday, August 21, 2014 - 8:19am
tags:
Novan, antibiotic resistance, Nitricil
Global fear of Ebola outbreak stokes a frenzy of new R&D, production plans
Fierce Biotech
Thursday, August 21, 2014 - 8:12am
tags:
R&D, ebola virus, Mapp Biopharmaceutical, Tekmira Pharmaceuticals
Illumina Announces Strategic Partnerships with AstraZeneca, Janssen and Sanofi to Redefine Companion Diagnostics for Oncology
Yahoo
Thursday, August 21, 2014 - 8:10am
tags:
Illumina, AstraZeneca, Janssen, Sanofi, diagnostics, cancer
Galena CEO Fired Following Stock-Promotions Scandal
TheStreet.com
Thursday, August 21, 2014 - 8:08am
tags:
Pharma CEOs, Galena Biopharma, Mark Ahn
Alcobra Starts Patient Enrollment for Mid-Stage Study on MDX
Yahoo/Zacks.com
Thursday, August 21, 2014 - 8:04am
tags:
Alcobra, MDX.V, Fragile X syndrome
AstraZeneca Is Tougher Target for Possible New Pfizer Bid
Bloomberg
Thursday, August 21, 2014 - 7:48am
tags:
Pfizer, AstraZeneca, M&A
Lilly's Ixekizumab Superior to Etanercept and Placebo in Phase 3 Psoriasis Studies
Yahoo
Thursday, August 21, 2014 - 7:45am
tags:
ixekizumab, etanercept, El Lilly, psoriasis
Yes, Call it a Comeback: Amicus Fabry Drug Posts Big Study Win
TheStreet.com
Wednesday, August 20, 2014 - 8:06am
tags:
Fabry's disease, Amicus, Migalastat HCl, GSK
5 Companies Developing New Cancer Drugs
Yahoo/Benzinga
Tuesday, August 19, 2014 - 4:40pm
tags:
cancer, OncoSec, ImmunoCellular, CDX-011, Celldex Therapeutics, DCVax-L, Northwest Biotherapeutics, Inovio
Depomed Prevails in Gralise® ANDA Litigation Blocking Generic Entry Until 2024
Yahoo
Tuesday, August 19, 2014 - 4:34pm
tags:
Depomed, generics, Gralise
Clinical failure for Merck KGaA's cancer vaccine dents subpopulation hopes
Fierce Biotech
Tuesday, August 19, 2014 - 4:24pm
tags:
vaccines, Merck KGaA, Oncothyreon, non-small cell lung cancer, Stimuvax
Allergan said to have contacted Salix about possible takeover: report
First Word Pharma
Tuesday, August 19, 2014 - 1:50pm
tags:
Allergan, Salix, M&A, Valeant Pharmaceuticals
You’ve got obesity all wrong: Zafgen CEO
CNBC
Tuesday, August 19, 2014 - 1:44pm
tags:
obesity, Zafgen, Pharma CEOs, beloranib
The Wildest Biotech Stock Out There
Yahoo/Benzinga
Tuesday, August 19, 2014 - 1:40pm
tags:
Vanda Pharmaceuticals
Amgen parathyroid drug succeeds in late-stage trial
Yahoo/Reuters
Tuesday, August 19, 2014 - 1:33pm
tags:
Amgen, AMG 416, hyperparathyroidism
Big Allergan Shareholders Pare Stakes as Valeant, Ackman Press Bid
WSJ Online
Tuesday, August 19, 2014 - 1:28pm
tags:
Allergan, Bill Ackman, Valeant Pharmaceuticals, M&A
Medtronic CEO says Covidien deal good for U.S. economy
Yahoo/Reuters
Tuesday, August 19, 2014 - 1:24pm
tags:
Medtronic, devices, Covidien, M&A
AstraZeneca reports positive Phase III data for experimental antibiotic ceftazidime-avibactam
First Word Pharma
Tuesday, August 19, 2014 - 9:50am
tags:
AstraZeneca, antibiotics, CAZ-AVI

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Inside a Scientific Paper Mill
In the Pipeline
Autoimmune Disease, Transformed?
In the Pipeline
Lose Your Crystalline Form and Go Amorphous
In the Pipeline
Alzheimer's Update: Infectious Agents and Gamma-Secretase Too
In the Pipeline
Obesity Without Metabolic Dysfunction?
In the Pipeline
New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.